
    
      This is a randomized, open-label, single dose, two-way crossover study to compare the
      pharmacokinetics and safety/tolerability of BR-UPS (Ulipristal acetate) 5 mg tablet with
      Inisia (Ulipristal acetate) 5 mg tablet in healthy female volunteers
    
  